Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Induction Agent Sub-Study Comparing Etomidate and Propofol)

NCT04934683 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT04934683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04934683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial (Induction Agent Sub-Study Comparing Etomidate and Propofol)
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
July 25, 2021
Completion date
April 25, 2027
Enrollment
6,254 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

major surgery